Ananth Thygarajan1, Arvil W Burks. 1. Division of Allergy and Immunology, Department of Pediatrics, Duke University Medical Center, Durham, North Carolina, USA. ananth.thyagarajan@duke.edu
Abstract
PURPOSE OF REVIEW: To review the American Academy of Pediatrics statement on the effects of early nutritional interventions on the development of atopic disease in infants and children. RECENT FINDINGS: Recent findings suggest that restriction of maternal diet during pregnancy and lactation does not play a major role in the development of allergic disease. In high-risk infants, exclusive breastfeeding for at least 4 months prevents or delays atopic dermatitis, cow milk allergy, and wheezing early in life. There is evidence that supplementing breastfeeding with a hydrolyzed formula protects against atopic disease, especially atopic dermatitis in at-risk infants. Finally, there is little evidence that delaying the introduction of complementary foods beyond 4-6 months of age has any protective effect against allergy. There is insufficient data that any dietary intervention beyond 4-6 months of age has any protective effect against developing atopic disease. SUMMARY: In high-risk infants, there is evidence that exclusive breastfeeding for at least 4 months, and delaying of complementary foods until 4-6 months, prevent the development of allergy. There is some evidence that supplementing hydrolyzed formulas in high-risk infants may delay or prevent allergic disease. There is no convincing evidence that maternal manipulation of diet during pregnancy or lactation, use of soy products, or infant dietary restrictions beyond 4-6 months has any effect on the development of atopic disease.
PURPOSE OF REVIEW: To review the American Academy of Pediatrics statement on the effects of early nutritional interventions on the development of atopic disease in infants and children. RECENT FINDINGS: Recent findings suggest that restriction of maternal diet during pregnancy and lactation does not play a major role in the development of allergic disease. In high-risk infants, exclusive breastfeeding for at least 4 months prevents or delays atopic dermatitis, cowmilk allergy, and wheezing early in life. There is evidence that supplementing breastfeeding with a hydrolyzed formula protects against atopic disease, especially atopic dermatitis in at-risk infants. Finally, there is little evidence that delaying the introduction of complementary foods beyond 4-6 months of age has any protective effect against allergy. There is insufficient data that any dietary intervention beyond 4-6 months of age has any protective effect against developing atopic disease. SUMMARY: In high-risk infants, there is evidence that exclusive breastfeeding for at least 4 months, and delaying of complementary foods until 4-6 months, prevent the development of allergy. There is some evidence that supplementing hydrolyzed formulas in high-risk infants may delay or prevent allergic disease. There is no convincing evidence that maternal manipulation of diet during pregnancy or lactation, use of soy products, or infant dietary restrictions beyond 4-6 months has any effect on the development of atopic disease.
Authors: Anne Zutavern; Inken Brockow; Beate Schaaf; Gabriele Bolte; Andrea von Berg; Ulrike Diez; Michael Borte; Olf Herbarth; H-Erich Wichmann; Joachim Heinrich Journal: Pediatrics Date: 2006-02 Impact factor: 7.124
Authors: Arne Høst; Susanne Halken; Antonella Muraro; Sten Dreborg; Bodo Niggemann; Rob Aalberse; Syed H Arshad; Andrea von Berg; Kai-Håkon Carlsen; Karel Duschén; Philippe A Eigenmann; David Hill; Catherine Jones; Michael Mellon; Göran Oldeus; Arnold Oranje; Cristina Pascual; Susan Prescott; Hugh Sampson; Magnus Svartengren; Ulrich Wahn; Jill A Warner; John O Warner; Yvan Vandenplas; Magnus Wickman; Robert S Zeiger Journal: Pediatr Allergy Immunol Date: 2008-02 Impact factor: 6.377
Authors: Leslie Elliott; John Henderson; Kate Northstone; Grace Y Chiu; David Dunson; Stephanie J London Journal: J Allergy Clin Immunol Date: 2008-05-12 Impact factor: 10.793
Authors: Susa Sorkio; David Cuthbertson; Sonja Bärlund; Antti Reunanen; Anita M Nucci; Carol L Berseth; Katriina Koski; Anne Ormisson; Erkki Savilahti; Ulla Uusitalo; Johnny Ludvigsson; Dorothy J Becker; John Dupré; Jeffrey P Krischer; Mikael Knip; Hans K Akerblom; Suvi M Virtanen Journal: Diabetes Metab Res Rev Date: 2010-03 Impact factor: 4.876
Authors: Tolly G Epstein; David I Bernstein; Linda Levin; Gurjit K Khurana Hershey; Patrick H Ryan; Tiina Reponen; Manuel Villareal; James E Lockey; Grace K Lemasters Journal: J Pediatr Date: 2011-02 Impact factor: 4.406
Authors: Mohammad D H Hawlader; Enbo Ma; Emiko Noguchi; Makoto Itoh; Shams E Arifeen; Lars Å Persson; Sophie E Moore; Rubhana Raqib; Yukiko Wagatsuma Journal: Trop Med Health Date: 2014-03-29